Changes in Cortical Activity in Stroke Survivors Undergoing Botulinum Neurotoxin Therapy for Treatment of Focal Spasticity

Changes in Cortical Activity in Stroke Survivors Undergoing Botulinum Neurotoxin Therapy for Treatment of Focal Spasticity

Background: Botulinum NeuroToxin-A (BoNT-A) relieves muscle spasticity and increases range of motion necessary for stroke rehabilitation. Determining the effects of BoNT-A therapy on brain neuroplasticity could help physicians customize its use and predict its outcome.Objective: The purpose of this...

Full description

Bibliographic Details
Main Authors:	Kaleb Vinehout, Kelsey Tynes, Miguel R. Sotelo, Allison S. Hyngstrom, John R. McGuire, Brian D. Schmit
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-12-01
Series:	Frontiers in Rehabilitation Sciences
Subjects:	stroke rehabilitation BoNT-A MRI activation connectivity
Online Access:	https://www.frontiersin.org/articles/10.3389/fresc.2021.735819/full

Similar Items

Botulinum neurotoxin X lacks potency in mice and in human neurons
by: Brieana M. Gregg, et al.
Published: (2024-03-01)

New 9-aminoacridine derivatives as inhibitors of Botulinum neurotoxins and P. falciparum malaria
by: Tot Mikloš, et al.
Published: (2013-01-01)

Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism
by: Robert P. Webb, et al.
Published: (2017-09-01)

Sheep Monoclonal Antibodies Prevent Systemic Effects of Botulinum Neurotoxin A1
by: Charles B. Shoemaker, et al.
Published: (2012-12-01)

Structural Analysis of Botulinum Neurotoxins Type B and E by Cryo-EM
by: Sara Košenina, et al.
Published: (2021-12-01)

Variability of Botulinum Toxins: Challenges and Opportunities for the Future
by: Christine Rasetti-Escargueil, et al.
Published: (2018-09-01)

Detection of Active BoNT/C and D by EndoPep-MS Using MALDI Biotyper Instrument and Comparison with the Mouse Test Bioassay
by: Ilenia Drigo, et al.
Published: (2020-12-01)

Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches
by: Christine Rasetti-Escargueil, et al.
Published: (2019-09-01)

Therapeutic Applications of Botulinum Neurotoxins in Veterinary Medicine
by: Lauretta Turin, et al.
Published: (2023-07-01)

Towards New Uses of Botulinum Toxin as a Novel Therapeutic Tool
by: Karen Perrow, et al.
Published: (2011-01-01)

Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E
by: Candace S. Bever, et al.
Published: (2019-07-01)

The destructive effect of botulinum neurotoxins on the SNARE protein: SNAP-25 and synaptic membrane fusion
by: Bin Lu
Published: (2015-06-01)

Discrimination of the Activity of Low-Affinity Wild-Type and High-Affinity Mutant Recombinant BoNT/B by a SIMA Cell-Based Reporter Release Assay
by: Frank Neuschäfer-Rube, et al.
Published: (2022-01-01)

Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E
by: Geoffrey Masuyer, et al.
Published: (2021-08-01)

The 25 kDa H<sub>CN</sub> Domain of Clostridial Neurotoxins Is Indispensable for Their Neurotoxicity
by: Julian Deppe, et al.
Published: (2020-11-01)

Current Status and Future Directions of Botulinum Neurotoxins for Targeting Pain Processing
by: Sabine Pellett, et al.
Published: (2015-11-01)

Cell-Based Reporter Release Assay to Determine the Potency of Proteolytic Bacterial Neurotoxins
by: Andrea Pathe-Neuschäfer-Rube, et al.
Published: (2018-09-01)

Rapid Microfluidic Assay for the Detection of Botulinum Neurotoxin in Animal Sera
by: Lmar Babrak, et al.
Published: (2016-01-01)

Structural and Biochemical Characterization of Botulinum Neurotoxin Subtype B2 Binding to Its Receptors
by: Jonathan R. Davies, et al.
Published: (2020-09-01)

Exploring the genetic background of the botulism neurotoxin BoNT/B2 in Spain
by: Sylvia Valdezate, et al.
Published: (2023-10-01)

Botulinum Toxin for Neuropathic Pain: A Review of the Literature
by: Hyun-Mi Oh, et al.
Published: (2015-08-01)

Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children—update and practice recommendations
by: Wolfgang H. Jost, et al.
Published: (2023-12-01)

Pathogenicity and virulence of Clostridium botulinum
by: Alexander M. Rawson, et al.
Published: (2023-12-01)

Botulinum Toxin Type A for the Treatment of Skin Ulcers: A Review Article
by: Waranaree Winayanuwattikun, et al.
Published: (2022-06-01)

Combined Effects of Isokinetic Training and Botulinum Toxin Type A on Spastic Equinus Foot in Patients with Chronic Stroke: A Pilot, Single-blind, Randomized Controlled Trial
by: Nicoletta Cinone, et al.
Published: (2019-04-01)

Association of Long-Term Treatment by Botulinum Neurotoxins and Occupational Therapy with Subjective Physical Status in Patients with Post-Stroke Hemiplegia
by: Toyohiro Hamaguchi, et al.
Published: (2019-08-01)

Botulinum toxin in the treatment of neuralgia and neuropathic pain
by: Katarzyna Mielniczek
Published: (2021-09-01)

SiMa Cells for a Serotype Specific and Sensitive Cell-Based Neutralization Test for Botulinum Toxin A and E
by: Nicola Bak, et al.
Published: (2017-07-01)

Botulinum Toxin for Pain Relief in Cancer Patients: A Systematic Review of Randomized Controlled Trials
by: Lorenzo Lippi, et al.
Published: (2024-03-01)

Botulinum Neurotoxin A4 Has a 1000-Fold Reduced Potency Due to Three Single Amino Acid Alterations in the Protein Receptor Binding Domain
by: William H. Tepp, et al.
Published: (2023-03-01)

Humoral Response of Buffaloes to a Recombinant Vaccine against Botulism Serotypes C and D
by: Denis Y. Otaka, et al.
Published: (2017-09-01)

Emerging Opportunities in Human Pluripotent Stem-Cells Based Assays to Explore the Diversity of Botulinum Neurotoxins as Future Therapeutics
by: Juliette Duchesne de Lamotte, et al.
Published: (2021-07-01)

Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies
by: Nicola Tambasco, et al.
Published: (2021-12-01)

Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A
by: Eugenia A. Panova, et al.
Published: (2023-02-01)

Preclinical Evidence for the Role of Botulinum Neurotoxin A (BoNT/A) in the Treatment of Peripheral Nerve Injury
by: Michael Adler, et al.
Published: (2022-04-01)

Multidimensional Effectiveness of Botulinum Toxin in Neuropathic Pain: A Systematic Review of Randomized Clinical Trials
by: Lorenzo Lippi, et al.
Published: (2022-04-01)

Examining the role of intrinsic and reflexive contributions to ankle joint hyper-resistance treated with botulinum toxin-A
by: Ronald C. van’t Veld, et al.
Published: (2023-02-01)

Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease
by: Bruno Bergmans, et al.
Published: (2023-01-01)

Best Clinical Practice in Botulinum Toxin Treatment for Children with Cerebral Palsy
by: Walter Strobl, et al.
Published: (2015-05-01)

Botulinum neurotoxin-A in a patient with post-stroke spasticity: a neurophysiological study
by: Safa Muntadher Fawzi, et al.
Published: (2023-07-01)